AI-Powered
Pathology
From discovery to diagnostics, AI powers our HALO software suite and services.
Transformative Digital Pathology Solutions
Advance your pathology research with our AI-powered image analysis and collaborative image management platforms.
Accelerate diagnostics and advance clinical research with a comprehensive suite of tools for image evaluation, collaboration, and clinical trial management.
HALO AP Dx is a FDA-cleared case-centric pathology platform that enables primary diagnosis, remote working, and other routine workflows in anatomic pathology.
HALO Clinical AI Solutions
CE-IVD marked AI tool that detects and grades prostate adenocarcinoma in core needle biopsy specimens
Quantifies PD-L1 expression in NSCLC IHC
Quantifies HER2, ER, PR, and Ki67 IHC expression levels in primary invasive breast cancer
Detects air bubbles, tissue folds, and other common artifacts present in H&E- and IHC-stained whole slide images
Quantifies tumor content and generates tumor density heatmap to guide ROI selection for macrodissection in NSCLC
Quantifies tumor content and generates tumor density heatmap to guide ROI selection for macrodissection in colorectal cancer
Our AI-enabled services offering includes Pharma Services and AWS hosted HALO Cloud Services.
Explore Our Integrated Platforms
Learn how all of our HALO products fit together to offer an end-to-end digital pathology workflow from basic science research to clinical diagnostics!
Indica Labs’ AI-Powered Pathology is Utilized in Labs Around the World
What Our Customers & Partners Have to Say
Moving our HALO deployments to the cloud with Cloud Services has decreased monthly costs substantially and has allowed us to easily collaborate with other research institutions across the country.
Dr. C. Dirk Keene, Professor
Pathology Leader, University of Washington Department of Laboratory Medicine
This is a truly groundbreaking partnership designed to accelerate the advent of next-generation AI-enabled solutions in cancer diagnostics. Leica Biosystems is proud to partner with Indica Labs to develop and deliver a world-class computational pathology solution to customers and their patients.
Gustavo Perez-Fernandez
President of Leica Biosystems
Indica Labs’ HALO is by far the most accurate, versatile, and user friendly digital image analysis platform that I have used. … HALO is a must have for any pathologist or scientist involved in quantifying immunohistochemical stains. In addition the HALO AI module is extremely easy to use. Within 20 minutes I was able to set up AI detection of tumor vs. normal tissue, as well as tumor epithelium vs stroma. HALO provides everything one needs for quantification of IHC for clinical and pre-clinical studies (of course with supervision of a pathologist). Best of all: it is fun, like a video game for Pathologists!
Senior Pathologist, AstraZeneca
At the National Cancer Institute, we have enterprise-wide cloud-based deployments of Indica’s digital pathology platform for both clinical and research use cases. Indica Labs has assisted us with migrating five large legacy Aperio eSlideManager databases into our centralized HALO environment. The Indica team engaged with our scientists and IT staff to plan and execute an approach for fast and efficient migrations with minimal downtime and zero data loss. All migrations were accomplished in two days or less.
Janelle Cortner
Director, Data Management and Analysis Program, National Cancer Institute
The deployment of HALO AP at IPATIMUP will allow us to dive into the important step of precise quantification of biomarkers. The use of Breast IHC AI and Lung PD-L1 AI from Indica Labs, under the umbrella of our demanding quality control system, promises efficient and high-quality tools for the best patient care.
Dr. Prof. Eloy
Head of the Pathology Laboratory of IPATIMUP and Professor of Medicine at The University of Porto
HALO is a user-friendly, and invaluable for quantification of multi-omics imaging data (MIBI, CODEX/Akoya multiplex stains, RNA-ISH/RNAscope). Cell segmentation, quantitation of tissue microarray data, aligning serial images, exporting quantitative data and .fcs files, it is incredible. The support team is incredibly responsive and collaborative.
Dr. Michael Kattah, MD, PhD
Assistant Professor, University of California, San Francisco
The implementation of HALO AP for digital tissue medicine at the University of Bern represents a major step towards streamlining diagnostic workflows and preparing for a future with AI-enabled pathology. We anticipate that deploying digital pathology in a secure AWS environment tailored to our institute’s needs will positively impact turnaround time, diagnostic quality and will ultimately contribute to improving patient care.
Prof. Dr. Aurel Perren
Institute of Tissue Medicine and Pathology at the University of Bern
The partnership with Indica Labs, a market leader in digital pathology, with interoperable workflow integration, will enable pathologists and labs to deliver faster, more accurate, and more reproducible answers using Lunit’s AI solution.
Dr. Brandon Suh, MD
CEO, Lunit
Our team of pathologists did an extensive comparative analysis of digital pathology platforms including HALO AP, and all pathologists in our group graded HALO AP as the platform of choice for case annotation, collaboration, and usability.
Doug Olson, CIO
Chief Information Officer, Versant Diagnostics
Using HALO AP has made an enormous difference to the way I work. It is much easier to review complex cases and consult with colleagues. Frankly, if you took away my digital pathology system I’d probably retire, the reason being I can do things faster and more accurately than I can with glass.
Dr. David Clark, MD
Clinical Lead for Digital Pathology Implementation, Nottingham University Hospitals NHS Trust
The selection of the HALO AP platform from Indica Labs represents a huge advance in our digital pathology capabilities. HALO AP’s user-friendly interface greatly enhances our ability to interpret complex morphological features. Digital pathology is not only streamlining diagnostic workflows but also laying the essential groundwork for AI-driven analysis. This integration marks a significant step toward more accurate, efficient, and data-driven pathology practices. By embracing these technologies, we are positioning ourselves at the forefront of the next generation in medical diagnostics.
Prof. Peter Regitnig
The Diagnostics & Research Institute for Pathology at the Medical University of Graz
Latest News
Catch up on the latest blogs, press releases, publications, and other news at Indica Labs.
Unlocking Deeper Insights with the HALO® High Dimensional Analysis Module
Extracting biological insights from highly multiplexed data requires both powerful image analysis tools and intuitive methods to navigate high-dimensional data. In this blog, we’ll cover the basics of dimensionality reduction and unsupervised clustering and explore our new High Dimensional Analysis module.
HALO®, HALO AI, and HALO Link 4.1 Features and Functionalities
In this blog post, you can learn about some of the new features in the 4.1 release including the new High Dimensional Analysis module, when to expect your chance to upgrade, and where to find user guides, release notes, and tutorial videos.
Open Pathology and AI Integrations: Empowering Labs with Choice
In digital pathology, advancements and proliferation in artificial intelligence (AI) and digital laboratory equipment are enabling streamlined workflows and new insights. However, they can also multiply the potential challenges laboratories face with software integration.
Announcing HALO® Vacuole, Object Colocalization BF, and Object Colocalization FL Modules Supporting Interactive Markups
We’re excited to announce the launch of the newly updated Vacuole, Object Colocalization BF, and Object Colocalization FL modules supporting interactive markups.
Webinars & Events
Check out our upcoming and most popular webinars and events!
Indica Labs’ Boston HALO® User Group Meeting
15 May 2025 | Indica Labs is pleased to announce our Boston HALO® User Group Meeting at Le Méridien Boston Cambridge on May 15 from 9:30 am – 4 pm.
Getting Started with Multiplex Fluorescence Image Analysis in HALO®
11 June 2025 | Learn the basics of multiplex fluorescence image analysis!
Getting Started with In Situ Hybridization in HALO®
22 May 2025 | Learn the basics of in situ hybridization image analysis!
Towards Open Pathology: Facilitating Development of Novel AI-based Tools for Digital Pathology through Collaboration and Integration
16 October 2022 | In this 1-hour workshop, Eric Runde, Chief Operating Officer at Indica Labs, will introduce Indica’s platforms, our collaborative approach to incorporating artificial intelligence (AI) into life science and clinical workflows, and the open pathology tools available to developers and industry partners. Dr. Peter Caie, Principal Scientist
Adoption of the HALO® Platform at Caris Life Sciences’ High Volume Digital Pathology Laboratory
17 October 2021 | In this one-hour pre-conference workshop, Indica Labs is pleased to host Dr. Matthew Oberley, Executive Medical Director at Caris Life Sciences, who will present a case study on deploying HALO AP® case management software in their high-volume, fully digital, anatomic pathology lab. Dr. Oberley will discuss
Masterclass Webinar: Intro to the HALO AI Toolbox
29 June 2023 | Join us for this 1-hour webinar to see a breakdown of the networks that make up HALO AI and applications suitable for each one.
Choosing The Right Foundation: Selecting And Deploying An Image Management System For Diagnostic Digital Pathology
18 May 2023 | In this 60-minute webinar, we will discuss considerations when selecting a digital pathology image management system for clinical diagnostics. In the first half of the event, we pose questions and suggest approaches that your group may adopt when evaluating diagnostic digital pathology platforms. A comprehensive Vendor
Transforming Pathology at Nottingham University Hospitals: Implementing Digital Pathology using HALO AP®
2 March 2023 | Learn about transformational change in how pathology services are delivered at Nottingham University Hospitals
HALO Prostate AI – A Tool for Automated Detection and Gleason Grading of Prostate Cancer
05 October 2022 | Join us for this 1-hour webinar to learn how to implement the HALO Prostate AI tool for prostate cancer detection and grading
Towards Open Pathology: Facilitating Development of Novel AI-based Tools for Digital Pathology through Collaboration and Integration
16 October 2022 | In this 1-hour workshop, Eric Runde, Chief Operating Officer at Indica Labs, will introduce Indica’s platforms, our collaborative approach to incorporating artificial intelligence (AI) into life science and clinical workflows, and the open pathology tools available to developers and industry partners. Dr. Peter Caie, Principal Scientist
Adoption of the HALO® Platform at Caris Life Sciences’ High Volume Digital Pathology Laboratory
17 October 2021 | In this one-hour pre-conference workshop, Indica Labs is pleased to host Dr. Matthew Oberley, Executive Medical Director at Caris Life Sciences, who will present a case study on deploying HALO AP® case management software in their high-volume, fully digital, anatomic pathology lab. Dr. Oberley will discuss
Masterclass Webinar: Intro to the HALO AI Toolbox
29 June 2023 | Join us for this 1-hour webinar to see a breakdown of the networks that make up HALO AI and applications suitable for each one.
Choosing The Right Foundation: Selecting And Deploying An Image Management System For Diagnostic Digital Pathology
18 May 2023 | In this 60-minute webinar, we will discuss considerations when selecting a digital pathology image management system for clinical diagnostics. In the first half of the event, we pose questions and suggest approaches that your group may adopt when evaluating diagnostic digital pathology platforms. A comprehensive Vendor
Transforming Pathology at Nottingham University Hospitals: Implementing Digital Pathology using HALO AP®
2 March 2023 | Learn about transformational change in how pathology services are delivered at Nottingham University Hospitals
HALO Prostate AI – A Tool for Automated Detection and Gleason Grading of Prostate Cancer
05 October 2022 | Join us for this 1-hour webinar to learn how to implement the HALO Prostate AI tool for prostate cancer detection and grading
Our Open Pathology Partners
